Wet Age-Related Macular Degeneration (AMD) Guide
What Is Wet Age-Related Macular Degeneration?
Understanding what happens inside the eye during wet AMD can help you make informed decisions about your care and recognize warning signs early.
The macula is a small, highly specialized area at the center of the retina. It contains a dense concentration of photoreceptor cells that allow you to read, drive, recognize faces, and see fine details. Because the macula handles your sharpest central vision, any damage to this tissue can have a noticeable effect on everyday activities even while your peripheral (side) vision remains intact.
Wet AMD develops when the body triggers the growth of new, abnormal blood vessels underneath or within the retina through a process called choroidal neovascularization (CNV). These fragile vessels are prone to leaking fluid, lipids, and blood into the surrounding macular tissue. The accumulation of this fluid distorts the delicate retinal layers, causing swelling that interferes with the macula's ability to process images clearly.
Dry AMD is characterized by the gradual buildup of small yellow deposits called drusen beneath the retina, along with slow thinning of the macular tissue. Wet AMD, by contrast, involves active fluid leakage and can cause more sudden vision changes over days or weeks rather than months or years. It is possible for dry AMD to progress into the wet form at any stage, which is why consistent monitoring is essential. You can learn more about the distinctions between these two forms in our guide to wet versus dry macular degeneration.
What Causes Wet Macular Degeneration?
Wet AMD results from a combination of age-related retinal changes and biological signals that trigger abnormal blood vessel growth beneath the macula.
As the retina ages, the layer of tissue beneath it (called the retinal pigment epithelium) can become less efficient at nourishing photoreceptor cells and clearing metabolic waste. When oxygen and nutrient supply to the macula is compromised, the body may respond by generating new blood vessels in an attempt to restore circulation. Unfortunately, these new vessels are structurally weak and leak easily, creating the fluid accumulation and bleeding that define wet AMD.
The primary chemical driver of abnormal vessel growth is a protein called vascular endothelial growth factor (VEGF). In a healthy eye, VEGF plays a normal role in blood vessel maintenance. In wet AMD, VEGF is overproduced in response to cellular stress, which stimulates rapid and disorganized new vessel formation. Modern anti-VEGF treatments for wet AMD specifically target this protein to slow or stop the leaking process.
Many patients with wet AMD initially had the dry form of the disease. Conversion from dry to wet AMD can occur at any point and is not always predictable. Patients who have been diagnosed with dry AMD in one or both eyes should maintain a regular monitoring schedule with their retina specialist. Home monitoring tools, such as the Amsler grid, can help detect subtle changes between office visits that may signal early conversion.
Symptoms of Wet Macular Degeneration
Wet AMD symptoms can appear suddenly and progress quickly, making it important to recognize them as early as possible.
The most common early sign of wet AMD is a noticeable decline in central vision. You may find that straight objects such as door frames, telephone poles, or lines of text appear bent or crooked. Some patients describe a blurry or dark spot near the center of their visual field that makes reading or recognizing faces more difficult. These changes can affect one eye initially, which sometimes makes them harder to notice.
Metamorphopsia, the medical term for visual distortion, is a hallmark symptom of wet AMD. Straight lines may appear wavy, bent, or irregular. This distortion results from fluid pushing the retinal layers out of their normal flat alignment. Checking an Amsler grid regularly at home is one of the most effective ways to catch this symptom early.
Unlike dry AMD, which typically progresses slowly, wet AMD can cause a rapid decline in vision within days to weeks. Some patients notice a sudden dark area or significant blur in their central vision that was not present the day before. Any abrupt change in vision should be treated as urgent, because early treatment can make a meaningful difference in preserving remaining sight.
As wet AMD progresses, activities that rely on sharp central vision become increasingly challenging. Reading small print, driving (especially at night), using a computer, and distinguishing colors or fine details may all become harder. Peripheral vision typically remains unaffected, so complete blindness from wet AMD alone is uncommon, but the impact on quality of life can be significant without treatment. Patients experiencing progressive central vision loss may benefit from low vision rehabilitation and aids designed to help maximize remaining sight.
How Wet AMD Is Diagnosed
Accurate, early diagnosis is critical for beginning treatment before irreversible macular damage occurs. Our retina specialists use several complementary tools to evaluate the health of your macula and retinal layers.
A comprehensive dilated exam allows your doctor to view the retina directly and look for signs of fluid, blood, or abnormal vessel growth beneath the macula. Dilating drops temporarily widen the pupil so the retinal structures can be examined in detail. This exam is the first step in identifying whether macular changes are present.
OCT is a noninvasive imaging technology that produces high-resolution cross-sectional images of the retina. OCT imaging can detect structural changes in the retina before a patient notices any symptoms, making it a valuable tool for early diagnosis (American Academy of Ophthalmology). It can measure macular thickness, identify even small pockets of subretinal or intraretinal fluid, and track changes over time with remarkable precision. You can learn more about this technology in our overview of OCT imaging and what your retinal scan shows.
During fluorescein angiography, a safe vegetable-based dye is injected into a vein in your arm and photographed as it travels through the blood vessels of the retina. This test reveals the exact location, size, and activity level of any leaking abnormal vessels. It helps our retina specialists determine the best treatment approach for your specific pattern of disease.
The Amsler grid is a simple tool made up of evenly spaced horizontal and vertical lines with a dot at the center. When you focus on the center dot, any areas of distortion, waviness, or missing lines may indicate macular changes. We encourage all AMD patients to test each eye separately with the Amsler grid on a regular basis at home and to contact us promptly if any new changes appear.
Frequently Asked Questions
The primary treatment for wet AMD is anti-VEGF therapy, which involves injecting medication directly into the eye to block the protein that drives abnormal blood vessel growth and leakage. Commonly used anti-VEGF medications include ranibizumab, aflibercept, and faricimab. These injections can stabilize vision and, in many cases, improve it when started promptly. Treatment schedules vary, but many patients begin with monthly injections and transition to a personalized treat-and-extend protocol based on their response.
Wet AMD primarily affects central vision, so total blindness from this condition alone is rare. However, without treatment, the leaking and scarring process can destroy enough macular tissue to cause severe central vision impairment. Peripheral vision is typically preserved, which means most patients retain the ability to navigate their surroundings. Early and consistent treatment offers the best chance of maintaining functional central vision.
Age is the strongest risk factor, with the vast majority of cases occurring in individuals over 60. Additional risk factors include a family history of AMD, smoking (which roughly doubles the risk), Caucasian ethnicity, cardiovascular disease, and obesity. Patients who already have dry AMD are at increased risk for developing the wet form, particularly those with large drusen or pigmentary changes in the macula.
With consistent anti-VEGF treatment, many patients are able to maintain stable or improved vision for years. Long-term outcomes depend on how early treatment begins, how the eye responds to injections, and whether treatment is maintained on the recommended schedule. Some patients eventually develop macular scarring that limits further visual gains, which is why ongoing monitoring and adherence to your treatment plan are so important.
While there is no guaranteed way to prevent wet AMD, certain lifestyle measures may help reduce your overall risk. Quitting smoking, eating a diet rich in leafy greens, fish, and colorful fruits, maintaining a healthy weight, and managing blood pressure and cholesterol all support retinal health. Patients with intermediate or advanced dry AMD may also benefit from AREDS2 nutritional supplements, which have been shown to reduce the risk of progression to advanced AMD. Regular home monitoring with an Amsler grid and keeping all scheduled eye appointments are equally essential.
You should schedule an evaluation promptly if you notice any sudden changes in your central vision, including new blurriness, dark spots, or distortion of straight lines. Patients already diagnosed with dry AMD should follow the monitoring schedule recommended by their retina specialist, typically every six to twelve months depending on disease severity. If you are over 60 and have not had a comprehensive dilated eye screening recently, scheduling one is a valuable step in protecting your long-term vision.
What our Patients say
4.8
Reviews
(3547)